‘WBUR’ Article Spotlights Hearing Regeneration Drug Trial Results

Preliminary results from Frequency Therapeutics' sensory hair cell regeneration drug, FX-322, show that it “stimulated hearing regeneration in humans for the first time,” according to an article on the “WBUR” website.